| Home | About Us | Products | Feedback | Co-operation | Contact Us | 中文 |
	Wondergen Bio-Medicine Technology Co.,Ltd. has been engaged in the development of Recombinant HCV and HIV Antigens since 2003. Our cloned, expressed and purified HCV and HIV antigens have been sourced by many world-leading ELISA Reagent Kit and Colloidal Gold Test Strip manufacturers and have all been approved by the National Center for Clinical Laboratory. Our specificity (>99.9%), sensitivity(<1ng/ml), batch difference (<0.001) and batch quantity (2g maxim) will contribute to the high accuracy for clients' research and clinical diagnosis practice, which has led to very high reputation in the immunodiagnosis industry.   Wondergen Recombinant Antigen samples are delivered free of charge within a week. Please fill in your postal address and detailed requirements through Feedback page.
	HCV  Core  antigens  (MW: 23Kd) HCV  NS3  antigens  (MW: 61Kd) HCV  NS4  antigens  (MW: 44Kd) HCV  NS5a  antigens  (MW: 52Kd) HCV  M5  antigens  (Multi-epitope includes: Core, NS3, NS4, NS5 and Env)  (MW: 62Kd) HIV-1  gp41  antigens  (MW: 41Kd) HIV-1  gp120  antigens  (MW: 42Kd) HIV-1  "O" group IDR    (MW: 40Kd) HIV-1  p24  antigens  (MW: 50Kd) HIV-2  gp36  antigens  (MW: 39Kd) HIV M      (Multi-epitope includes: gp120, gp41, "O" IDR and gp36)      (MW: 63Kd) Syphilis  TP15  antigens  (MW: 40Kd) Syphilis  TP17  antigens  (MW: 42Kd) Syphilis  TP47  antigens  (MW: 55Kd) Syphilis  TP M  antigens  (Multi-epitope includes: TP15, TP17 and TP47)  (MW: 85Kd) Wondergen Bio-Medicine Technology Co.,Ltd.was founded in response to the urgent needs of SARS diagnosis in China's Silicon Valley in 2003. Its Founder Dr Jiang was one of the major scientists responsible for the SAS research after completing his PHD in Bioscience and many years of research in America. Since then, Wondergen has been developed by a group of scholars, led by Dr Richard Jiang, attracted from both national key universities and abroad. Wondergen has been awarded many national innovation funds and rewards and has owned one international patent and four national patents, with some other patent rights at application stage.